Conclusion
In this retrospective analysis, concomitant Impella® to ECMO support in eCPR patients was associated with significantly lower in-hospital mortality. Also, weaning of VA-ECMO was more often successful in the ECMO+Impella® group. ECMO+Impella® group showed significantly higher rates of blood transfusions and acute kidney failure requiring dialysis.
The realization of a simultaneous mechanical circulatory assist device might be a beneficial therapy option in eCPR patients. Further studies are needed to evaluate the clinical relevance and impact of Impella® devices in eCPR patients.